Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Post by u2bobon Nov 17, 2017 12:12pm
170 Views
Post# 26984631

Time to step into the light...

Time to step into the light...
Diagnos Inc... has good management ... good product...just needs to get in the news more...and a I/R department would certainly help ...when you look on our web site below it only shows 3 articules...and the last one is in French only... great write up ...but not getting out to the investing world...the Journal articule states how we are going up against Google in the Medical field ...would make for a great story in a national paper in Canada or the States...as a shareholder with a vested interest in this company ....I would like to hear more in our NR's which are vague on info about these 3rd party deals...maybe this is were a I/R firm could help...feels like the last 6 months everyone else is closing in !
 

Lets hope we hear something from Bayer pilot soon... or a made in Quebec plan

Good luck...
Bob

Bullboard Posts